Loop Capital began coverage on shares of Astera Labs (NASDAQ:ALAB – Free Report) in a report issued on Thursday morning, MarketBeat reports. The firm issued a buy rating and a $250.00 price objective on the stock.
ALAB has been the topic of a number of other research reports. Barclays set a $165.00 price target on Astera Labs in a report on Thursday, January 15th. JPMorgan Chase & Co. increased their target price on shares of Astera Labs from $180.00 to $215.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 5th. BNP Paribas Exane assumed coverage on shares of Astera Labs in a research report on Thursday, November 20th. They issued an “outperform” rating on the stock. Morgan Stanley reaffirmed an “overweight” rating and issued a $210.00 price target on shares of Astera Labs in a research report on Wednesday, December 3rd. Finally, Raymond James Financial initiated coverage on Astera Labs in a research note on Friday, November 21st. They issued a “hold” rating on the stock. Fifteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $195.89.
Get Our Latest Research Report on Astera Labs
Astera Labs Price Performance
Astera Labs (NASDAQ:ALAB – Get Free Report) last released its earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. During the same quarter last year, the company earned $0.37 EPS. Astera Labs’s quarterly revenue was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, research analysts expect that Astera Labs will post 0.34 earnings per share for the current fiscal year.
Insider Buying and Selling at Astera Labs
In other news, General Counsel Philip Mazzara sold 10,000 shares of the firm’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $117.47, for a total transaction of $1,174,700.00. Following the completion of the transaction, the general counsel directly owned 128,084 shares of the company’s stock, valued at approximately $15,046,027.48. This trade represents a 7.24% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Sanjay Gajendra sold 94,971 shares of the stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $11,758,359.51. Following the completion of the transaction, the chief operating officer directly owned 1,531,301 shares of the company’s stock, valued at approximately $189,590,376.81. The trade was a 5.84% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 216,792 shares of company stock worth $26,777,569. Corporate insiders own 12.50% of the company’s stock.
Institutional Investors Weigh In On Astera Labs
Institutional investors and hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. boosted its holdings in shares of Astera Labs by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock worth $2,300,344,000 after acquiring an additional 84,365 shares in the last quarter. State Street Corp raised its position in Astera Labs by 32.5% in the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after purchasing an additional 760,358 shares during the last quarter. Geode Capital Management LLC raised its position in Astera Labs by 4.5% in the 4th quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock valued at $403,598,000 after purchasing an additional 104,935 shares during the last quarter. Fred Alger Management LLC boosted its stake in Astera Labs by 25.5% in the fourth quarter. Fred Alger Management LLC now owns 1,934,688 shares of the company’s stock worth $321,855,000 after purchasing an additional 393,250 shares in the last quarter. Finally, Morgan Stanley grew its holdings in shares of Astera Labs by 33.0% during the fourth quarter. Morgan Stanley now owns 1,934,467 shares of the company’s stock worth $321,818,000 after purchasing an additional 480,009 shares during the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.
Trending Headlines about Astera Labs
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Loop Capital initiated coverage with a Buy and a $250 price target, highlighting Astera’s role in AI datacenter connectivity and providing a sizable upside thesis for the stock. Read More.
- Positive Sentiment: An initiation piece argues Astera can still be an “AI winner,” reinforcing investor interest in its connectivity chips and software for high‑bandwidth servers. Read More.
- Positive Sentiment: Recent quarterly results showed a revenue and EPS beat and management set modest Q1 EPS guidance, supporting the growth story behind multiple analyst Buy ratings. Read More.
- Neutral Sentiment: Analysts and outlets flag that ALAB is trading at a premium valuation and faces stiff competition — that supports a cautious stance despite strong end‑market demand. Read More.
- Neutral Sentiment: Coverage pieces note mixed share‑price signals vs growth expectations, leaving valuation and timing as the primary debate among investors. Read More.
- Neutral Sentiment: Several writeups describe a shifting investment narrative as analysts update models — positive for long‑term thesis but creating short‑term opinion dispersion. Read More.
- Negative Sentiment: Coverage reports that a margin “reset” tied to an Amazon AI deal could compress near‑term margins, raising execution and profitability concerns for investors focused on margin expansion. Read More.
- Negative Sentiment: Insider selling: Astera’s General Counsel sold 10,000 shares (disclosed early March), which some investors interpret as a near‑term negative signal even though insiders still hold large stakes. Read More.
Astera Labs Company Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Stories
- Five stocks we like better than Astera Labs
- “I just bought 10,000 shares of a $5 stock…”
- 3 Signs You May Want to Switch Financial Advisors
- How JPMorgan’s $8,000 Gold Call Will Leave Most Retirement Accounts Behind
- Silver Is the New Oil—And the World’s Running Dry
- Central banks just did something they haven’t done since 1967
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
